Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [517]
News [1431]
Articles [66]
Editorials [2]
Conferences [72]
elearning [5]
Uncommon BRAF mutation in melanoma sensitive to MEK inhibitor drug therapy
Uncommon BRAF mutation in melanoma sensitive to MEK inhibitor drug therapy
Immunostimulatory nanoparticles enhance tumour immunotherapy
Immunostimulatory nanoparticles enhance tumour immunotherapy
Researchers discover molecule in immune system that could help treat dangerous skin cancer
Researchers discover molecule in immune system that could help treat dangerous skin cancer
Tumour microenvironment helps skin cancer cells resist drug treatment
Tumour microenvironment helps skin cancer cells resist drug treatment
Coffee consumption inversely associated with risk of most common form of skin cancer
Coffee consumption inversely associated with risk of most common form of skin cancer
Sun exposure and cutaneous HPV infection found synergistic in skin cancers
Sun exposure and cutaneous HPV infection found synergistic in skin cancers
Dabrafenib offers improved progression-free survival for melanoma patients
Dabrafenib offers improved progression-free survival for melanoma patients
Asbestos and shift work boost work-related cancer deaths to over 8,000 a year in UK
Asbestos and shift work boost work-related cancer deaths to over 8,000 a year in UK
New drug is 'greatest advance' for basal cell skin cancer
New drug is 'greatest advance' for basal cell skin cancer
ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma
ASCO 2012: New MEK inhibitor, trametinib, improves survival in advanced melanoma

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation